Global Bronchitis Treatment Market Size, Share, and COVID-19 Impact Analysis, By Type (Acute Bronchitis and Chronic Bronchitis), By Drug Class (Antibiotics, Anti-Inflammatory Drugs, Bronchodilators, Mucolytic), End User (Hospital Pharmacies, Retail Pharmacies, and Other End Users), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030

Industry: Healthcare
RELEASE DATE Apr 2023
REPORT ID SI1689
PAGES 225
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis by Type
      2. Market Attractiveness Analysis by Drug Class
      3. Market Attractiveness Analysis by End User
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Increasing elderly population
    3. Restraints
      1. Increasing demand for efficient treatment
    4. Opportunities
      1. Technological Advancements
    5. Challenges
      1. Strict government guidelines
  6. Global Bronchitis Treatment Market Analysis and Projection, By Type
    1. Segment Overview
    2. Acute Bronchitis
    3. Chronic Bronchitis
  7. Global Bronchitis Treatment Market Analysis and Projection, By Drug Class
    1. Segment Overview
    2. Antibiotics
    3. Anti-Inflammatory Drugs
    4. Bronchodilators
    5. Mucolytic
  8. Global Bronchitis Treatment Market Analysis and Projection, By End Users
    1. Segment Overview
    2. Hospital Pharmacies
    3. Retail Pharmacies
    4. Other End Users
  9. Global Bronchitis Treatment Market, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  10. Global Bronchitis Treatment Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Global Bronchitis Treatment Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1. AstraZeneca
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2. NOVARTIS AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  GlaxoSmithKline plc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4. Dr. Reddy’s Laboratories Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.  Melinta Therapeutics
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6. Sanofi Aventis
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7. Boehringer Ingelheim International GmbH
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Cipla Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9. Lupin Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Merck and Co. Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11. Sun Pharmaceuticals Industries Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12. Teva Pharmaceutical Industries Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.   Viatris Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.   Cadila Healthcare Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15.   Akorn Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    16. Linconal Pharmaceutical Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Bronchitis Treatment Market, By Type, 2022-2032(USD Billion)
  2. Global Acute Bronchitis, Bronchitis Treatment Market, By Region, 2022-2032(USD Billion)
  3. Global Chronic Bronchitis, Bronchitis Treatment Market, By Region, 2022-2032(USD Billion)
  4. Global Bronchitis Treatment Market, By Drug Class, 2022-2032(USD Billion)
  5. Global Antibiotics, Bronchitis Treatment Market, By Region, 2022-2032(USD Billion)
  6. Global Anti-Inflammatory Drugs, Bronchitis Treatment Market, By Region, 2022-2032(USD Billion)
  7. Global Bronchodilators, Bronchitis Treatment Market, By Region, 2022-2032(USD Billion)
  8. Global Mucolytic, Bronchitis Treatment Market, By Region, 2022-2032(USD Billion)
  9. Global Bronchitis Treatment Market, By End Users, 2022-2032(USD Billion)
  10. Global Hospital Pharmacies, Bronchitis Treatment Market, By Region, 2022-2032(USD Billion)
  11. Global Retail Pharmacies, Bronchitis Treatment Market, By Region, 2022-2032(USD Billion)
  12. Global Other End Users, Bronchitis Treatment Market, By Region, 2022-2032(USD Billion)
  13. Global Bronchitis Treatment Market, By Region, 2022-2032(USD Billion)
  14. North America Bronchitis Treatment Market, By Type, 2022-2032(USD Billion)
  15. North America Bronchitis Treatment Market, By Drug Class, 2022-2032(USD Billion)
  16. North America Bronchitis Treatment Market, By End Users, 2022-2032(USD Billion)
  17. U.S. Bronchitis Treatment Market, By Type, 2022-2032(USD Billion)
  18. U.S. Bronchitis Treatment Market, By Drug Class, 2022-2032(USD Billion)
  19. U.S. Bronchitis Treatment Market, By End Users, 2022-2032(USD Billion)
  20. Canada Bronchitis Treatment Market, By Type, 2022-2032(USD Billion)
  21. Canada Bronchitis Treatment Market, By Drug Class, 2022-2032(USD Billion)
  22. Canada Bronchitis Treatment Market, By End Users, 2022-2032(USD Billion)
  23. Mexico Bronchitis Treatment Market, By Type, 2022-2032(USD Billion)
  24. Mexico Bronchitis Treatment Market, By Drug Class, 2022-2032(USD Billion)
  25. Mexico Bronchitis Treatment Market, By End Users, 2022-2032(USD Billion)
  26. Europe Bronchitis Treatment Market, By Type, 2022-2032(USD Billion)
  27. Europe Bronchitis Treatment Market, By Drug Class, 2022-2032(USD Billion)
  28. Europe Bronchitis Treatment Market, By End Users, 2022-2032(USD Billion)
  29. Germany Bronchitis Treatment Market, By Type, 2022-2032(USD Billion)
  30. Germany Bronchitis Treatment Market, By Drug Class, 2022-2032(USD Billion)
  31. Germany Bronchitis Treatment Market, By End Users, 2022-2032(USD Billion)
  32. France Bronchitis Treatment Market, By Type, 2022-2032(USD Billion)
  33. France Bronchitis Treatment Market, By Drug Class, 2022-2032(USD Billion)
  34. France Bronchitis Treatment Market, By End Users, 2022-2032(USD Billion)
  35. U.K. Bronchitis Treatment Market, By Type, 2022-2032(USD Billion)
  36. U.K. Bronchitis Treatment Market, By Drug Class, 2022-2032(USD Billion)
  37. U.K. Bronchitis Treatment Market, By End Users, 2022-2032(USD Billion)
  38. Italy Bronchitis Treatment Market, By Type, 2022-2032(USD Billion)
  39. Italy Bronchitis Treatment Market, By Drug Class, 2022-2032(USD Billion)
  40. Italy Bronchitis Treatment Market, By End Users, 2022-2032(USD Billion)
  41. Spain Bronchitis Treatment Market, By Type, 2022-2032(USD Billion)
  42. Spain Bronchitis Treatment Market, By Drug Class, 2022-2032(USD Billion)
  43. Spain Bronchitis Treatment Market, By End Users, 2022-2032(USD Billion)
  44. Asia Pacific Bronchitis Treatment Market, By Type, 2022-2032(USD Billion)
  45. Asia Pacific Bronchitis Treatment Market, By Drug Class, 2022-2032(USD Billion)
  46. Asia Pacific Bronchitis Treatment Market, By End Users, 2022-2032(USD Billion)
  47. Japan Bronchitis Treatment Market, By Type, 2022-2032(USD Billion)
  48. Japan Bronchitis Treatment Market, By Drug Class, 2022-2032(USD Billion)
  49. Japan Bronchitis Treatment Market, By End Users, 2022-2032(USD Billion)
  50. China Bronchitis Treatment Market, By Type, 2022-2032(USD Billion)
  51. China Bronchitis Treatment Market, By Drug Class, 2022-2032(USD Billion)  
  52. China Bronchitis Treatment Market, By End Users, 2022-2032(USD Billion)
  53. India Bronchitis Treatment Market, By Type, 2022-2032(USD Billion)
  54. India Bronchitis Treatment Market, By Drug Class, 2022-2032(USD Billion)
  55. India Bronchitis Treatment Market, By End Users, 2022-2032(USD Billion)
  56. South America Bronchitis Treatment Market, By Type, 2022-2032(USD Billion)
  57. South America Bronchitis Treatment Market, By Drug Class, 2022-2032(USD Billion)
  58. South America Bronchitis Treatment Market, By End Users, 2022-2032(USD Billion)
  59. Brazil Bronchitis Treatment Market, By Type, 2022-2032(USD Billion)
  60. Brazil Bronchitis Treatment Market, By Drug Class, 2022-2032(USD Billion)
  61. Brazil Bronchitis Treatment Market, By End Users, 2022-2032(USD Billion)
  62. The Middle East and Africa Bronchitis Treatment Market, By Type, 2022-2032(USD   Billion)
  63. The Middle East and Africa Bronchitis Treatment Market, Drug Class, 2022-2032(USD   Billion)
  64. The Middle East and Africa Bronchitis Treatment Market, By End Users, 2022-2032(USD Billion)
  65. UAE Bronchitis Treatment Market, By Type, 2022-2032(USD Billion)
  66. UAE Bronchitis Treatment Market, By Drug Class, 2022-2032(USD Billion)
  67. UAE Bronchitis Treatment Market, By End Users, 2022-2032(USD Billion) 
  68. South Africa Bronchitis Treatment Market, By Type, 2022-2032(USD Billion)
  69. South Africa Bronchitis Treatment Market, By Drug Class, 2022-2032(USD Billion)
  70. South Africa Bronchitis Treatment Market, By End Users, 2022-2032(USD Billion)

List of Figures 

  1. Global Bronchitis Treatment Market Segmentation
  2. Bronchitis Treatment Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Bronchitis Treatment Market
  9. Top Winning Strategies, 2022-2032
  10. Top Winning Strategies, By Development, 2022-2032(%)
  11. Top Winning Strategies, By Company, 2022-2032
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers:  Bronchitis Treatment Market
  20. Bronchitis Treatment Market Segmentation, By Type
  21. Bronchitis Treatment Market, For Acute Bronchitis, By Region, 2022-2032 ($ Billion)
  22. Bronchitis Treatment Market, For Chronic Bronchitis, By Region, 2022-2032 ($ Billion)
  23. Bronchitis Treatment Market Segmentation, By Drug Class
  24. Bronchitis Treatment Market, For Antibiotics, By Region, 2022-2032 ($ Billion)
  25. Bronchitis Treatment Market, For Anti-Inflammatory Drugs, By Region, 2022-2032 ($ Billion)
  26. Bronchitis Treatment Market, For Bronchodilators, By Region, 2022-2032 ($ Billion)
  27. Bronchitis Treatment Market, For Mucolytic, By Region, 2022-2032 ($ Billion)
  28. Bronchitis Treatment Market Segmentation, By End Users
  29. Bronchitis Treatment Market, For Hospital Pharmacies, By Region, 2022-2032 ($ Billion)
  30. Bronchitis Treatment Market, For Retail Pharmacies, By Region, 2022-2032 ($ Billion)
  31. Bronchitis Treatment Market, For Other End Users, By Region, 2022-2032 ($ Billion)
  32. AstraZeneca: Net Sales, 2022-2032 ($ Billion)
  33. AstraZeneca: Revenue Share, By Segment, 2022 (%)
  34. AstraZeneca: Revenue Share, By Region, 2022 (%)
  35. NOVARTIS AG: Net Sales, 2022-2032 ($ Billion)
  36. NOVARTIS AG: Revenue Share, By Segment, 2022 (%)
  37. NOVARTIS AG: Revenue Share, By Region, 2022 (%)
  38. GlaxoSmithKline plc: Net Sales, 2022-2032 ($ Billion)
  39. GlaxoSmithKline plc: Revenue Share, By Segment, 2022 (%)
  40. GlaxoSmithKline plc: Revenue Share, By Region, 2022 (%)
  41. Dr. Reddy's Laboratories Ltd.: Net Sales, 2022-2032 ($ Billion)
  42. Dr. Reddy's Laboratories Ltd.: Revenue Share, By Segment, 2022 (%)
  43. Dr. Reddy's Laboratories Ltd.: Revenue Share, By Region, 2022 (%)
  44. Melinta Therapeutics: Net Sales, 2022-2032 ($ Billion)
  45. Melinta Therapeutics: Revenue Share, By Segment, 2022 (%)
  46. Melinta Therapeutics: Revenue Share, By Region, 2022 (%)
  47. Sanofi Aventis: Net Sales, 2022-2032 ($ Billion)
  48. Sanofi Aventis: Revenue Share, By Segment, 2022 (%)
  49. Sanofi Aventis: Revenue Share, By Region, 2022 (%)
  50. Boehringer Ingelheim International GmbH: Net Sales, 2022-2032 ($ Billion)
  51. Boehringer Ingelheim International GmbH: Revenue Share, By Segment, 2022 (%)
  52. Boehringer Ingelheim International GmbH: Revenue Share, By Region, 2022 (%)
  53. Cipla Ltd.: Net Sales, 2022-2032 ($ Billion)
  54. Cipla Ltd.: Revenue Share, By Segment, 2022 (%)
  55. Cipla Ltd.: Revenue Share, By Region, 2022 (%)
  56. Lupin Ltd.: Net Sales, 2022-2032 ($ Billion)
  57. Lupin Ltd.: Revenue Share, By Segment, 2022 (%)
  58. Lupin Ltd.: Revenue Share, By Region, 2022 (%)
  59. Merck and Co. Inc.: Net Sales, 2022-2032 ($ Billion)
  60. Merck and Co. Inc.: Revenue Share, By Segment, 2022 (%)
  61. Merck and Co. Inc.: Revenue Share, By Region, 2022 (%)
  62. Sun Pharmaceutical Industries Ltd.: Net Sales, 2022-2032 ($ Billion)
  63. Sun Pharmaceutical Industries Ltd.: Revenue Share, By Segment, 2022 (%)
  64. Sun Pharmaceutical Industries Ltd.: Revenue Share, By Region, 2022 (%)
  65. Teva Pharmaceutical Industries Ltd.: Net Sales, 2022-2032 ($ Billion)
  66. Teva Pharmaceutical Industries Ltd.: Revenue Share, By Segment, 2022 (%)
  67. Teva Pharmaceutical Industries Ltd.: Revenue Share, By Region, 2022 (%)
  68. Viatris Inc.: Net Sales, 2022-2032 ($ Billion)
  69. Viatris Inc.: Revenue Share, By Segment, 2022 (%)
  70. Viatris Inc.: Revenue Share, By Region, 2022 (%)
  71. Cadila Healthcare Ltd.: Net Sales, 2022-2032 ($ Billion)
  72. Cadila Healthcare Ltd.: Revenue Share, By Segment, 2022 (%)
  73. Cadila Healthcare Ltd.: Revenue Share, By Region, 2022 (%)
  74. Akorn Inc.: Net Sales, 2022-2032 ($ Billion)
  75. Akorn Inc.: Revenue Share, By Segment, 2022 (%)
  76. Akorn Inc.: Revenue Share, By Region, 2022 (%)
  77. Lincoln Pharmaceuticals Ltd: Net Sales, 2022-2032 ($ Billion)
  78. Lincoln Pharmaceuticals Ltd: Revenue Share, By Segment, 2022 (%)
  79. Lincoln Pharmaceuticals Ltd: Revenue Share, By Region, 2022 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2021
Tables & Figures:149
Pages:225
Countries covered:15
Companies covered::16
Forecast CAGR:5.2%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies